# Buying a GLP-1 With No Insurance: What It Really Costs

By Nora Bissett, Pricing Editor (https://glpwatchdog.org/authors/nora-bissett) | Published: 2026-08-15 | Updated: 2026-11-10

Canonical page: https://glpwatchdog.org/research/cheapest-glp1-without-insurance

> Compounded semaglutide runs $79 to $299 a month across 556 sellers; tirzepatide $99 to $399. The spread is four to one for the same molecule. This explains what decides where you land.

## Key points

- Compounded semaglutide: low $79, median $189.99, 90th percentile $299 across 423 priced rows.
- Compounded tirzepatide: low $99, median $264, 90th percentile $399 across 372 priced rows.
- The lowest advertised figure is usually a twelve-month prepay rate, not the month-to-month price.
- A 28-day billing cycle charges 13 times a year, not 12, and the price card rarely says so.

Paying cash changes the question entirely. With insurance you are asking what your plan will approve; without it you are asking what the market charges, and [the market charges an enormous range for the same molecule](https://glpwatchdog.org/research/how-much-glp1-prices-actually-vary). When we measured the register on August 15, 2026, across its 556 sellers, compounded semaglutide ran from about **$79** a month to **$299** at the ninetieth percentile, with a median near **$190**. Tirzepatide ran **$99** to **$399**, median **$264**.

That spread, roughly four to one for the same drug, is the most useful fact for a cash payer, and it is why a shopping page is worth more than a coupon. Below are the tiers, what makes the cheap end cheap, and the four questions that decide whether the number you are quoted is the number you will pay.

> **Read every register figure on this page as compounded, not brand.** The manufacturers' own cash prices are set out separately below, and no compounded seller is offering you Wegovy or Zepbound at $79. A compounded preparation is a different thing: not FDA-approved, not reviewed for that specific preparation, and made by a pharmacy the seller may not name. The price gap is real, and so is the difference in oversight.

## What the market looks like

*Standing monthly cash prices across this register, measured August 15, 2026*

|   | Compounded semaglutide | Compounded tirzepatide |
| --- | --- | --- |
| Lowest on record | $79 | $99 |
| Median | $189.99 | $264 |
| 90th percentile | $299 | $399 |
| Priced rows we hold | 423 | 372 |

The distribution matters more than the minimum. If you are being quoted above the ninetieth percentile, you are paying a premium. It may buy a named pharmacy, a real clinician relationship or a flat-price guarantee, all of which are worth money, or it may buy nothing. If you are being quoted at the very bottom, the questions below are the ones that tell you why.

## The brand floor has dropped to meet it

The comparison a cash payer makes is no longer compounded at $190 against brand at a thousand. Both manufacturers now sell direct, and two of their products are pills that start at **$149** a month.[4][6] The Wegovy pill costs **$299** a month at 25 mg, the dose its label sets for maintenance.[2][4] That is the same figure as the ninetieth percentile for compounded semaglutide in our August measurement.

*Manufacturer self-pay prices per month, read from the manufacturers' own pages on October 17, 2026[4][5][6]*

| Product | Starting dose | Maintenance doses |
| --- | --- | --- |
| Wegovy pill (semaglutide) | $149 (1.5 mg) | 4 mg is $199; both 9 mg and 25 mg are $299 |
| Wegovy pen (semaglutide) | $199 for the first two fills, new patients, through Dec 31, 2026 | $349 at every dose to 2.4 mg; $399 for Wegovy HD 7.2 mg |
| Foundayo (orforglipron) | $149 (0.8 mg) | $149 to $349 by dose; some tiers are temporary cuts that end Dec 31, 2026 |
| Zepbound KwikPen (tirzepatide) | $299 (2.5 mg) | 5 mg is $399; 7.5 mg and up is $449 with each refill inside 45 days, or $499 to $699 if a refill is late |

Two cautions. The headline figures are starting doses and introductory fills, and the maintenance column is what a year of treatment costs. The federal TrumpRx site lists the same starting figures for these products, so it is a doorway to the manufacturer programs rather than a cheaper price ([every TrumpRx GLP-1 price](https://glpwatchdog.org/research/trumprx-glp1-prices)).[7] And these prices are set to move: Novo's pages say its pricing will be updated after December 31, 2026, and Lilly's reduced Foundayo tiers end that day (see [Foundayo cost](https://glpwatchdog.org/research/foundayo-cost)).[4][6] Novo's announced cut to a $675 list price on January 1, 2027 is a different number. The company says it does not change self-pay prices; it matters to people whose insurance cost-sharing is tied to list price.[8]

## What makes the cheap end cheap

A $79 monthly price is not usually a loss leader or a mistake. It is a set of trade-offs, and they are legible if you know where to look.

- **A long prepayment.** The lowest advertised figure is very often the twelve-month rate. The month-to-month price at the same seller can be double it. That is the work “as low as” does in an ad. At [NuestraRx](https://glpwatchdog.org/reviews/nuestrarx), compounded semaglutide is $159 on the monthly plan and $139 a month on the six-month plan, which is paid up front as $834. [Ironvale RX](https://glpwatchdog.org/reviews/ironvale-rx) publishes $129 a month for semaglutide and $169 for tirzepatide, both on a 12-month plan billed annually, and shows no monthly price before checkout. [CoreAge Rx](https://glpwatchdog.org/reviews/coreage-rx) charges $79 a month for compounded semaglutide and $129 for compounded tirzepatide at every dose, with no membership fee.
- **A starting dose.** Where pricing rises with the dose, the advertised number is the bottom rung of the ladder, and the cost of a full titrated course is a different figure entirely. [Vivoro](https://glpwatchdog.org/reviews/vivoro) posts a price for each dose: a 30-day order of compounded tirzepatide runs from $249 at 1.5 mg a week to $399 at 13.5 mg. [ElliotMeds](https://glpwatchdog.org/reviews/elliotmeds) prices by strength too: a one-month supply of compounded semaglutide runs from $129 for its 1 mg option to $279 for 10 mg.
- **No named pharmacy.** Most cheap sellers do not say who compounds the medication, which means you cannot check that pharmacy’s inspection or accreditation record before buying.
- **Asynchronous care.** A questionnaire reviewed by a clinician costs a fraction of a live video visit. That is legitimate and legal in most states, and it is less contact than some people need.
- **Volume.** Some sellers are cheaper because they are larger, and their compounding partner charges them less. That is the good version of a low price.

## The four questions that decide your real price

1. **What is the billing cycle?** A 28-day cycle bills 13 times a year, not 12, so “$149 a month” is $1,937 a year rather than $1,788. The cycle usually appears in the terms, not on the price card.
2. **Is that the month-to-month rate or a prepay rate?** Ask for both. The gap is frequently larger than the gap between two different sellers. At [Panterra Health](https://glpwatchdog.org/reviews/panterra-health) one refill of compounded semaglutide is $150, or $100 a refill when you buy three for $300 in one payment, and neither renews on its own. At [Found](https://glpwatchdog.org/reviews/found), compounded semaglutide is $289 month to month, billed every 4 weeks, and $169 a month only on a 12-month plan paid up front.
3. **Does the price change when the dose goes up?** Flat pricing at every dose is valuable. Confirm it rather than assuming it, because “all doses” sometimes means all doses up to a cap.
4. **What is included?** Medication, consult, shipping, labs. Two sellers at the same headline number can be selling materially different things, and shipping plus the consult is usually where the difference sits. Free shipping also says nothing about [whether the medication stays cold in transit](https://glpwatchdog.org/research/who-tells-you-how-your-glp1-ships).

Those questions have concrete answers at real sellers. [Vyvron](https://glpwatchdog.org/reviews/vyvron) bills its program every four weeks, which comes to 13 charges a year, and charges the same whichever GLP-1 the provider prescribes. [Totara Health](https://glpwatchdog.org/reviews/totara-health) posts its 3-, 6- and 12-month plans as single totals beside the one-month price, so the prepay gap is on the page, and [FormBlends](https://glpwatchdog.org/reviews/formblends) shows its whole price table, renewals included, before the first health question. [LunaRx](https://glpwatchdog.org/reviews/lunarx-health) shows starting prices on its homepage but sets the actual price after a provider review.

On dose and inclusions, [Apex MD](https://glpwatchdog.org/reviews/apex-md) charges the same at every dose and includes quarterly lab work and unlimited provider visits. [Helix Wellness Rx](https://glpwatchdog.org/reviews/helix-wellness-rx) also charges one rate at every dose, but shows it only after the medical intake. [Intimate Rose](https://glpwatchdog.org/reviews/intimate-rose) folds medication, delivery and provider check-ins into its plan with no membership fee, while [Glow](https://glpwatchdog.org/reviews/glow) bills its compounded program separately from its coaching app. [Juna](https://glpwatchdog.org/reviews/juna) says its compounded semaglutide price includes doctor visits, medication and support, at $149 for the first month and $199 a month in its FAQ.

> **Tools that do this arithmetic.** The [cost-per-pound calculator](https://glpwatchdog.org/tools/glp1-cost-per-pound-calculator) normalizes across plans, the [savings calculator](https://glpwatchdog.org/tools/glp1-savings-calculator) compares a cash price against an insured copay, and [the price tracker](https://glpwatchdog.org/price-tracker) shows which prices have moved.

One seller that answers those questions on a public page is [Lavender Sky Health](https://glpwatchdog.org/reviews/lavender-sky-health), which lists every plan at every pharmacy it uses and bills the consult separately from the medication.

## Check insurance first, even if you assume no

Spend ten minutes on this before you commit to cash, and on a low income, ten more on the [manufacturers’ free-medicine programs](https://glpwatchdog.org/research/glp1-patient-assistance-programs). Coverage for weight management is poor and [frequently excluded outright](https://glpwatchdog.org/research/does-cigna-cover-zepbound-and-wegovy). But an obstructive sleep apnea diagnosis, established cardiovascular disease or type 2 diabetes changes the question, because those are indications with completed outcomes trials behind them and insurers treat them differently from weight alone. If one of them fits, the approved brand is the one to ask about: we list the sellers that price [brand Zepbound for sleep apnea](https://glpwatchdog.org/best/tirzepatide-providers/zepbound-for-sleep-apnea) and those that price [the brands approved for type 2 diabetes](https://glpwatchdog.org/best/glp1-for-type-2-diabetes).

If a plan does cover it, the comparison is between your copay and these cash figures, and the copay does not always win. A high-deductible plan can leave you paying the full brand price for months. People on Medicare Part D who meet the criteria have their own route: a $50 copay for Wegovy, Foundayo or the Zepbound KwikPen through the Medicare GLP-1 Bridge.[9] Our guide to [getting a GLP-1 covered](https://glpwatchdog.org/research/how-to-get-a-glp1-covered-by-insurance) walks the prior-authorization route, and the [state Medicaid checker](https://glpwatchdog.org/tools/state-medicaid-glp1-checker) covers the public-program side.

Some services are built around that check rather than around cash. [Klarity Health](https://glpwatchdog.org/reviews/klarity-health) is a marketplace of independent providers who take insurance or self-pay, and it accepts HSA and FSA cards. [MDLive](https://glpwatchdog.org/reviews/mdlive) bills insurance and prescribes brand-name drugs such as Wegovy and Zepbound only at a primary-care visit, which is open through select health plans. [Twentyeight Health](https://glpwatchdog.org/reviews/twentyeight-health) charges $19.99 a month for its Weight Care membership and leaves the medication to the pharmacy, which bills it separately and often through insurance or Medicaid. [Life IV Weight Loss](https://glpwatchdog.org/reviews/life-iv-weight-loss), a Michigan practice, bills its visits to insurance or charges $99 for a self-pay first visit, and the brand-name prescription is filled through insurance or a manufacturer pharmacy.

## Where the cheap end stops being a bargain

Below the prices in this register there is another market: peptides sold as “research chemicals” and labeled not for human consumption, at a fraction of any figure above. There is no prescriber, no pharmacy, no accountable party and no way to establish what is in the vial. This register does not list those sellers, and nothing on this page should be read as covering them. Our piece on [that market](https://glpwatchdog.org/research/buy-tirzepatide-research-chemical) explains what it is and what it costs people.

## Common questions

## Frequently asked questions

### What is the cheapest GLP-1 you can get without insurance?

In our August 15, 2026 measurement the lowest standing monthly cash prices were about $79 for compounded semaglutide and $99 for compounded tirzepatide, with medians near $190 and $264. Those are compounded preparations, and the lowest figures usually require a long prepayment. The cheapest FDA-approved options are the Wegovy pill and Foundayo, both $149 a month at their starting doses through the manufacturers in October 2026; the Wegovy pill is $299 at its 25 mg maintenance dose.

### Why is compounded semaglutide so much cheaper than Wegovy?

It is a different product made by a different kind of facility. Wegovy is manufactured by Novo Nordisk under Good Manufacturing Practice and approved by FDA; a compounded preparation is made by a pharmacy from bulk active ingredient and has not been reviewed for safety, effectiveness or manufacturing quality as that specific preparation. The gap in price tracks a gap in oversight.

### Is the cheapest seller the best choice?

Not automatically, and the questions above are how you tell. A cheap price that comes with a named dispensing pharmacy, flat dosing and month-to-month billing is a real find. The same price behind a twelve-month prepay, a starting-dose-only rate and no named pharmacy is a different offer at the same number.

### Can I use a manufacturer coupon without insurance?

Generally no. The Wegovy and Zepbound savings cards require commercial insurance, and are excluded for anyone on Medicare, Medicaid, VA or TRICARE. What cash payers do have is the manufacturers' own direct programs, which ran from $149 to $699 a month in October 2026 depending on product and dose. Those are the brand prices to compare against these compounded figures. People on Medicare Part D who meet the criteria can get Wegovy, Foundayo or the Zepbound KwikPen for a $50 copay through the Medicare GLP-1 Bridge, a CMS program scheduled to end on December 31, 2027.

### Do these prices include the consultation?

Sometimes. It is one of the four questions to ask, because a low medication price plus a separate membership or consult fee can total more than a seller whose higher figure already includes them. Every review in this register records what the monthly price covers, field by field.

## See the current numbers

The register figures on this page were computed on August 15, 2026, and the manufacturer prices were read on October 17, 2026; both will drift. [The cheapest semaglutide board](https://glpwatchdog.org/best/cheapest-semaglutide) and [the cheapest tirzepatide board](https://glpwatchdog.org/best/cheapest-tirzepatide) are generated from the current record, and the [monthly tirzepatide ranking](https://glpwatchdog.org/best/cheapest-tirzepatide/monthly) sorts sellers by their lowest standing monthly cash price. Every [seller review](https://glpwatchdog.org/reviews) carries its own price rows with the date each was read. For a cash-only view of the same records, with the median standing price next to the manufacturer self-pay rates, see our [semaglutide](https://glpwatchdog.org/best/semaglutide-providers/without-insurance) and [tirzepatide](https://glpwatchdog.org/best/tirzepatide-providers/without-insurance) boards without insurance.

## References

1. U.S. Food and Drug Administration FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA. 2026. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
2. U.S. National Library of Medicine WEGOVY (semaglutide) injection — prescribing information. DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=WEGOVY
3. U.S. National Library of Medicine ZEPBOUND (tirzepatide) injection — prescribing information. DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ZEPBOUND
4. Novo Nordisk Wegovy® Savings Offer — self-pay pricing for the Wegovy pill, pen and Wegovy HD. novocare.com. 2026. https://www.novocare.com/obesity/products/wegovy/savings-offer.html
5. Eli Lilly and Company Zepbound® — LillyDirect self-pay pricing. lilly.com, LillyDirect. 2026. https://www.lilly.com/lillydirect/zepbound
6. Eli Lilly and Company Foundayo™ — LillyDirect self-pay pricing. lilly.com, LillyDirect. 2026. https://www.lilly.com/lillydirect/foundayo
7. U.S. Department of Health and Human Services TrumpRx — most-favored-nation medication price listings. trumprx.gov. 2026. https://trumprx.gov/
8. Novo Nordisk Novo Nordisk announces significant reduction in US list price for Wegovy®, Ozempic®, and Rybelsus® (semaglutide medicines), building on continued efforts to expand access. PR Newswire, February 24, 2026. 2026. https://www.prnewswire.com/news-releases/novo-nordisk-announces-significant-reduction-in-us-list-price-for-wegovy-ozempic-and-rybelsus-semaglutide-medicines-building-on-continued-efforts-to-expand-access-302695705.html
9. Centers for Medicare & Medicaid Services Medicare GLP-1 Bridge: information for providers. CMS. 2026. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-providers

---

Cite as: GLP Watchdog, Nora Bissett, "Buying a GLP-1 With No Insurance: What It Really Costs", published 2026-08-15, updated 2026-11-10. https://glpwatchdog.org/research/cheapest-glp1-without-insurance

Canonical HTML page: https://glpwatchdog.org/research/cheapest-glp1-without-insurance

Medical disclaimer: Nothing here is medical advice. We report on this subject; we do not treat anyone. Whether to begin a medication, supplement, or treatment, whether to adjust it, and whether to stop are questions for a clinician licensed to answer them, who knows your history.
